U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Quinapril Hydrochloride Tablet
Status: Currently in Shortage
»Date first posted: 01/19/2023
»Therapeutic Categories: Cardiovascular

Expand all

Aurobindo Pharma USA (Reverified 07/02/2024)

Company Contact Information:
866-850-2876

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90) Discontinued Discontinuation of the manufacture of the drug
Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) Discontinued Discontinuation of the manufacture of the drug
Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) Discontinued Discontinuation of the manufacture of the drug
Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90) Discontinued Discontinuation of the manufacture of the drug

Chartwell Molecular Holdings LLC (New 07/02/2024)

Company Contact Information:
845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Tablet, 5 mg (NDC 62135-484-60) Available
Tablet, 10 mg (NDC 62135-485-90) Available
Tablet, 20 mg (NDC 62135-486-90) Available
Tablet, 40 mg (NDC 62135-487-90) Available

Lupin Pharmaceuticals, Inc. (Reverified 05/18/2024)

Company Contact Information:
866-587-4617

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09) Unavailable Requirements related to complying with good manufacturing practices
Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09) Unavailable Requirements related to complying with good manufacturing practices
Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09) Unavailable Requirements related to complying with good manufacturing practices
Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09) Unavailable Requirements related to complying with good manufacturing practices

Pfizer Inc. (Revised 07/15/2024)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Accupril, Tablet, 40 mg (NDC 0071-0535-23) Unavailable Next Delivery and Estimated Recovery: TBD Delay in shipping of the drug
Accupril, Tablet, 10 mg (NDC 0071-0530-23) Unavailable Next Delivery and Estimated Recovery: TBD Delay in shipping of the drug
Accupril, Tablet, 20 mg (NDC 0071-0532-23) Unavailable Next Delivery and Estimated Recovery: TBD Delay in shipping of the drug
Accupril, Tablet, 5 mg (NDC 0071-0527-23) Unavailable Next Delivery and Estimated Recovery: TBD Delay in shipping of the drug

Solco Healthcare US, LLC (Reverified 06/17/2024)

Company Contact Information:
866-931-9829

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Tablet, 5 mg (NDC 43547-410-09) Unavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time. Shortage of an active ingredient
Tablet, 10 mg (NDC 43547-411-09) Unavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time. Shortage of an active ingredient
Tablet, 20 mg (NDC 43547-412-09) Unavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time. Shortage of an active ingredient
Tablet, 40 mg (NDC 43547-413-09) Unavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time. Shortage of an active ingredient
Back to Top